Navigation Links
SoluLinK Introduces ChromaLink(TM) Biotin Labeling Kit to Biotinylate and Measure With One Reagent
Date:1/29/2008

SAN DIEGO, Jan. 29 /PRNewswire/ --- SoluLinK, Inc., a leader in biomolecular conjugation products and kits, announced the introduction of their newest product, the ChromaLink Biotin Labeling Kit, a biotinylation reagent with a built-in measurement signature that comes as a complete, easy-to-use kit. ChromaLink is an innovative biotinylation reagent that includes a direct, non-destructive, UV measurement of incorporated biotin within a single reagent.
(Photo: http://www.newscom.com/cgi-bin/prnh/20080129/LATU010)

-- Complete Kit: All necessary reagents included as well as a foolproof

protocol provided on a flash drive

-- Built-in Quantitative Signal: Incorporated biotin quantified by simple

absorbance -- no HABA or fluoro-reporter assay needed -- only a simple

UV scan needed to measure

-- Versatile: Labels 25 micrograms to 1 mg of antibody

-- Safe and Economical: Water-soluble, mild on antibodies -- no DMF needed

"ChromaLink is the first in a line of our products designed to address existing market needs with effective technology, supplied in a complete, easy to use format. This line of products will provide complete assay solutions for specific market applications. SoluLinK's continuous and ongoing innovation of conjugation chemistry has provided significant contributions to our customers' and collaborators' ability to build greater value into their products. SoluLinK has established a strong leadership position in conjugation and continues to actively build, maintain, and manage our products and patented IP," observed Steve DeGraw, President of SoluLinK.

About SoluLinK

SoluLinK is a leader in the development of conjugation reagents, kits, and OEM services for the life sciences, diagnostic, and pharmaceutical communities. SoluLinK develops, manufactures, and markets bioconjugation products and services. Their proprietary bioconjugation linking chemistry is used to link proteins, oligonucleotides, peptides, and antibodies to each other or to a wide range of surfaces. Rapidly growing applications for SoluLinK's products include the conjugation of biomolecules for research assay, diagnostic, and pharmaceutical products. SoluLinK's proprietary ChromaLink Biotin Labeling Kit for biotinylation is one example. It is also the first product introduced from the pipeline of a new, easy to use kits that will help to enhance assay performance and measurement for customers in a broad range of large markets. SoluLinK markets these products both directly and through distributors and licensing partners world-wide. SoluLinK is a privately held company located in San Diego, California. For more information, please visit http://www.solulink.com.


'/>"/>
SOURCE SoluLinK, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Biomatrica Introduces SampleWare(R) Version 3.0 Software for Laboratory Sample Management
2. Aton Pharma Introduces Expanded Distribution of Lacrisert(R) (hydroxypropyl cellulose ophthalmic insert) at Hawaiian Eye
3. Biomerica Introduces a New 15 Minute Home Test for Allergies to Cats and Receives CE Mark Approval for Home Use
4. Microfabrica Introduces Set of Miniature Building Blocks for Minimally-Invasive Medical Devices
5. Caliper Life Sciences Introduces Zephyr SPE Workstation to Improve Efficiency of Solid Phase Extraction
6. Finesse Introduces TruBio(TM) IOQ
7. Nikon Instruments Introduces NIS-Elements Software for Eclipse Ti-E Live-Cell Applications
8. EDDA Technology Introduces Universal Enterprise Solution - Enabling 2D/3D/4D Advanced Clinical Applications on Existing PACS Workstations
9. H&V Introduces HVision Technology Platform to Accelerate Development of Breakthrough Products
10. WHO Introduces the Helminth Drug Initiative With Special Supplement in the Expert Opinion on Drug Discovery
11. Sigma-Aldrich Introduces N-TER Nanoparticle siRNA Transfection System for Delivery of siRNA Into Difficult-to-Transfect Cell Types
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... , ... Disappearing forests and increased emissions are the main causes of the ... Especially those living in larger cities are affected by air pollution related diseases. , ... pollution-affected countries globally - decided to take action. , “I knew I had to ...
(Date:10/11/2017)... ... October 11, 2017 , ... Singh Biotechnology today announced that ... SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of Transcription 3) B VHH13 ... cross the cell membrane and bind intracellular STAT3 and inhibit its function. Dysregulation ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give it ... Nanoparticle), a technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). ...
(Date:10/10/2017)... ... October 10, 2017 , ... Dr. Bob Harman, founder and ... San Diego Rotary Club. The event entitled “Stem Cells and Their ... 300+ attendees. Dr. Harman, DVM, MPVM was joined by two human doctors: Peter ...
Breaking Biology Technology:
(Date:4/5/2017)... , April 5, 2017  The Allen Institute ... Allen Cell Explorer: a one-of-a-kind portal and dynamic digital ... 3D imaging data, the first application of deep learning ... human stem cell lines and a growing suite of ... platform for these and future publicly available resources created ...
(Date:4/5/2017)... LONDON , April 4, 2017 KEY ... is anticipated to expand at a CAGR of 25.76% ... neurodegenerative diseases is the primary factor for the growth ... full report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The ... of product, technology, application, and geography. The stem cell ...
(Date:4/3/2017)... April 3, 2017  Data captured by ... platform, detected a statistically significant association between ... to treatment and objective response of cancer ... to predict whether cancer patients will respond ... as well as to improve both pre-infusion potency ...
Breaking Biology News(10 mins):